BIOSIG TECHNOLOGIES INC (BSGM) Stock Overview
USA - NASDAQ:BSGM - US09073N3008 - Common Stock
BSGM Key Statistics, Chart & Performance
The current stock price of BSGM is 6.1 USD. In the past month the price increased by 32.61%. In the past year, price increased by 256.73%.
BSGM Latest News, Press Relases and Analysis
BSGM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.98 | 216.98B | ||
| ISRG | INTUITIVE SURGICAL INC | 61.56 | 190.00B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.09 | 149.02B | ||
| SYK | STRYKER CORP | 28.02 | 141.06B | ||
| MDT | MEDTRONIC PLC | 16.45 | 116.69B | ||
| BDX | BECTON DICKINSON AND CO | 12.57 | 51.42B | ||
| IDXX | IDEXX LABORATORIES INC | 52.33 | 50.28B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.48 | 49.01B | ||
| RMD | RESMED INC | 25.48 | 36.81B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.34 | 34.24B | ||
| DXCM | DEXCOM INC | 36.67 | 26.75B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.43 | 26.26B |
Related stock screener links
About BSGM
Company Profile
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. The company is headquartered in Westport, Connecticut and currently employs 5 full-time employees. The company went IPO on 2014-09-22. The firm has an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. PURE EP is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time. PURE EP is designed to enhance clinical decision-making and improve clinical workflows for all types of arrhythmias, even the challenging procedures for cardiac arrhythmias, like ventricular tachycardia and atrial fibrillation.
Company Info
BIOSIG TECHNOLOGIES INC
55 Greens Farms Road
Westport CONNECTICUT 06880 US
CEO: Kenneth L. Londoner
Employees: 5
Phone: 12034095444
BIOSIG TECHNOLOGIES INC / BSGM FAQ
What does BIOSIG TECHNOLOGIES INC do?
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. The company is headquartered in Westport, Connecticut and currently employs 5 full-time employees. The company went IPO on 2014-09-22. The firm has an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. PURE EP is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time. PURE EP is designed to enhance clinical decision-making and improve clinical workflows for all types of arrhythmias, even the challenging procedures for cardiac arrhythmias, like ventricular tachycardia and atrial fibrillation.
What is the stock price of BIOSIG TECHNOLOGIES INC today?
The current stock price of BSGM is 6.1 USD. The price increased by 37.08% in the last trading session.
Does BSGM stock pay dividends?
BSGM does not pay a dividend.
What is the ChartMill technical and fundamental rating of BSGM stock?
BSGM has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is BSGM stock listed?
BSGM stock is listed on the Nasdaq exchange.
Is BIOSIG TECHNOLOGIES INC (BSGM) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BSGM.
BSGM Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to BSGM. When comparing the yearly performance of all stocks, BSGM is one of the better performing stocks in the market, outperforming 97.09% of all stocks.
BSGM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BSGM. Both the profitability and financial health of BSGM have multiple concerns.
BSGM Financial Highlights
Over the last trailing twelve months BSGM reported a non-GAAP Earnings per Share(EPS) of -0.81. The EPS increased by 80.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.52% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BSGM Forecast & Estimates
7 analysts have analysed BSGM and the average price target is 10.2 USD. This implies a price increase of 67.21% is expected in the next year compared to the current price of 6.1.